AU2707192A - Substituted hydroquinone derivatives - Google Patents

Substituted hydroquinone derivatives

Info

Publication number
AU2707192A
AU2707192A AU27071/92A AU2707192A AU2707192A AU 2707192 A AU2707192 A AU 2707192A AU 27071/92 A AU27071/92 A AU 27071/92A AU 2707192 A AU2707192 A AU 2707192A AU 2707192 A AU2707192 A AU 2707192A
Authority
AU
Australia
Prior art keywords
halogen
group
lower alkyl
formula
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU27071/92A
Other versions
AU661722B2 (en
Inventor
Gerhard Dr. Fischer
Gottfried Dr. Sedelmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2707192A publication Critical patent/AU2707192A/en
Application granted granted Critical
Publication of AU661722B2 publication Critical patent/AU661722B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Inorganic Insulating Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compounds of the formula I <IMAGE> in which R4 is lower alkyl and R1 is either hydroxyl, halogen, a group of the formula -P(=O)(R5)R6 (Ia), a group of the formula -P<+)<R7)(R8)R9X <-> (Ib) or a group of the formula -Si(R7)(R8)R9 (Ic), M is methylene, R2 is hydrogen or a group of the formula <IMAGE> and R3 is hydrogen or halogen or R1 is hydroxyl or lower alkoxy, M is carbonyl, R2 is hydrogen and R3 is halogen, R5 and R6 in each case independently of one another represent lower alkyl, lower alkoxy, N,N-di-lower alkylamino or benzyl, benzyloxy, phenyl or phenoxy, each of which is unsubstituted or mono- or disubstituted on the phenyl ring, it being possible for the substituents of the phenyl ring in each case to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, R7, R8 and R9 in each case independently of one another represent lower alkyl, unsubstituted or mono- or disubstituted phenyl, it being possible for the substituents of the phenyl ring in each case to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, or represent furyl, X<-> is the anion of a hydrohalic acid, a lower alkane-sulphonic acid, a halo-lower alkanesulphonic acid or a benzenesulphonic acid which is unsubstituted or monosubstituted by lower alkyl or halogen and in which Y either represents a direct bond and R10 is lower alkyl, allyl, cyano, lower alkanesulphonyl, halo-lower alkanesulphonyl, benzyl which is unsubstituted or mono- or disubstituted on the phenyl ring, it being possible for the substituents of the phenyl ring to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, or is benzenesulphonyl which is unsubstituted or monosubstituted by lower alkyl or halogen, or in which Y is a group of the formula -(C=O)- (Ie) or a group of the formula -(C=S)- (If) and R10 is halogen, lower alkyl, halo-lower alkyl, lower alkoxy, lower alkenyloxy, phenyl-lower alkenyloxy, halo-lower alkoxy, lower alkylthio or phenyl, phenoxy, phenylthio, benzyl, benzyloxy or benzylthio, each of which is unsubstituted or mono-or disubstituted on the phenyl ring, it being possible for the substituents of the phenyl ring in each case to be selected from the group which consists of lower alkyl, lower alkoxy, nitro and halogen, with the proviso that in a compound I in which R1 is a group Ib in which R7, R8 and R9 in each case denote unsubstituted phenyl and X<-> is the bromide ion, M is methylene, R2 is hydrogen and R4 is methyl, R3 is other than hydrogen, and with the further proviso that in a compound I in which R1 is hydroxyl, M is methylene, R2 is hydrogen and R4 is methyl or ethyl, and R3 is other than hydrogen, can be used for the preparation of compounds of the formula <IMAGE> in which R3 is halogen and R4 is lower alkyl and R10 and Y have the abovementioned meanings, and their salts. They are prepared by methods known per se.
AU27071/92A 1991-10-17 1992-10-15 Substituted hydroquinone derivatives Ceased AU661722B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3042/91 1991-10-17
CH304291 1991-10-17

Related Child Applications (2)

Application Number Title Priority Date Filing Date
AU36614/95A Division AU691344B2 (en) 1991-10-17 1995-11-02 Substituted hydroquinone derivatives
AU36615/95A Division AU691345B2 (en) 1991-10-17 1995-11-02 Substituted hydroquinone derivatives

Publications (2)

Publication Number Publication Date
AU2707192A true AU2707192A (en) 1993-04-22
AU661722B2 AU661722B2 (en) 1995-08-03

Family

ID=4247322

Family Applications (3)

Application Number Title Priority Date Filing Date
AU27071/92A Ceased AU661722B2 (en) 1991-10-17 1992-10-15 Substituted hydroquinone derivatives
AU36614/95A Expired - Fee Related AU691344B2 (en) 1991-10-17 1995-11-02 Substituted hydroquinone derivatives
AU36615/95A Expired - Fee Related AU691345B2 (en) 1991-10-17 1995-11-02 Substituted hydroquinone derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU36614/95A Expired - Fee Related AU691344B2 (en) 1991-10-17 1995-11-02 Substituted hydroquinone derivatives
AU36615/95A Expired - Fee Related AU691345B2 (en) 1991-10-17 1995-11-02 Substituted hydroquinone derivatives

Country Status (20)

Country Link
US (1) US5290939A (en)
EP (1) EP0542671B1 (en)
JP (1) JPH05213808A (en)
KR (1) KR930007940A (en)
AT (1) ATE147059T1 (en)
AU (3) AU661722B2 (en)
CA (1) CA2080683A1 (en)
DE (1) DE59207805D1 (en)
DK (1) DK0542671T3 (en)
ES (1) ES2096062T3 (en)
FI (1) FI924651A (en)
GR (1) GR3022221T3 (en)
HU (1) HUT62250A (en)
IL (1) IL103447A0 (en)
MX (1) MX9205989A (en)
NO (1) NO180441C (en)
NZ (1) NZ244751A (en)
RU (1) RU2095339C1 (en)
TW (1) TW209869B (en)
ZA (1) ZA928003B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693807A (en) * 1992-10-14 1997-12-02 Ciba-Geigy Corporation Substituted hydroquinone derivatives
DE69418789T2 (en) * 1993-08-05 1999-12-02 Hoechst Marion Roussel, Inc. 2- (Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl) benzofuran-7-carbamate derivatives, their preparation and use as acetylcholinesterase inhibitors
CN100546970C (en) * 2006-05-18 2009-10-07 中国科学院广州化学研究所 A kind of synthetic method of bromo benzoic ether
CN104769006B (en) 2012-09-07 2017-03-08 英派尔科技开发有限公司 Regioregular copolymer and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600719A (en) * 1973-03-02 1986-07-15 Ciba Geigy Corporation Tetrahydropyridine and piperidine derivatives
CH592656A5 (en) * 1973-03-02 1977-10-31 Ciba Geigy Ag
CH609054A5 (en) * 1975-11-26 1979-02-15 Ciba Geigy Ag Process for the preparation of a novel piperidine derivative
JPS63139180A (en) * 1986-12-02 1988-06-10 Tanabe Seiyaku Co Ltd Carboxylic acid derivative
FR2619111B1 (en) * 1987-08-07 1991-01-11 Synthelabo (PIPERIDINYL-4) METHYL-2 TETRAHYDRO-1,2,3,4 9H-PYRIDO (3,4-B) INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2626877B1 (en) * 1988-02-05 1991-04-05 Delalande Sa ALKYLIC OR BENZYL ETHERS OF PHENOL, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
EP0352581A3 (en) * 1988-07-28 1990-07-04 F. Hoffmann-La Roche Ag Ethylene diaminmonoamide derivatives

Also Published As

Publication number Publication date
AU691344B2 (en) 1998-05-14
DE59207805D1 (en) 1997-02-13
RU2095339C1 (en) 1997-11-10
NO924024D0 (en) 1992-10-16
AU3661595A (en) 1996-01-11
AU691345B2 (en) 1998-05-14
KR930007940A (en) 1993-05-20
ATE147059T1 (en) 1997-01-15
US5290939A (en) 1994-03-01
NO924024L (en) 1993-04-19
DK0542671T3 (en) 1997-01-20
FI924651A (en) 1993-04-18
GR3022221T3 (en) 1997-04-30
MX9205989A (en) 1993-08-31
HU9203233D0 (en) 1992-12-28
CA2080683A1 (en) 1993-04-18
EP0542671B1 (en) 1997-01-02
FI924651A0 (en) 1992-10-14
ES2096062T3 (en) 1997-03-01
NO180441C (en) 1997-04-23
EP0542671A1 (en) 1993-05-19
NO180441B (en) 1997-01-13
AU3661495A (en) 1996-01-04
JPH05213808A (en) 1993-08-24
IL103447A0 (en) 1993-03-15
TW209869B (en) 1993-07-21
AU661722B2 (en) 1995-08-03
ZA928003B (en) 1993-04-19
NZ244751A (en) 1995-02-24
HUT62250A (en) 1993-04-28

Similar Documents

Publication Publication Date Title
RU92004429A (en) DERIVATIVES 2- (1-PIPERASINIL) -4-PHENYL-CYCLO-ALKANOPYRIDINE
EP0895996A3 (en) Process for preparing highly pure organosilicon disulfanes
HUT77442A (en) 1,2,3,4-tetrahydroquinoxalindione derivatives and pharmaceutical compositions containing them
KR890006650A (en) Tetrahydro-furo and -thieno [2,3-C] pyridine, their use as pharmaceutical preparations and methods for their preparation
KR900015721A (en) New Methods and Compounds
AU3661595A (en) Substituted hydroquinone derivatives
KR880002828A (en) Dihydropyridine derivatives and pharmaceutical compositions thereof
CA2378945A1 (en) Multi-dose erythropoietin formulations
ES543793A0 (en) PROCEDURE FOR THE PREPARATION OF NEW A-ETILBEN-ZOL DERIVATIVES WITH A SUBSTITUTED PIPERIDINOPROPANOLIC GROUP AND ITS QUADRONARY AMONIC AND ACID ADDITIONAL SALTS
EP0308785A3 (en) Dihydropyridine ethers, processes for their preparation and their utilisation
AU5785386A (en) Berban derivatives
ATE47842T1 (en) ANTI-FUNCTIONAL AGENT.
DK0763516T3 (en) Preparation and use of pure enantiomers of 8-halo-6-hydroxyoctanoic acids, their alkyl esters and their salts with pure enantiomers of alpha-methylbenzylamine
GB1456033A (en) Phosphorus-containing 1,2,4-triazole derivatives having pesticidal properties
RU99108453A (en) SUBSTITUTED HETEROCYCLES AS ANTI-TUMOR AGENTS
GB1470751A (en) 1-substituted-6-phenyl-4h-s-triazolo-4,3-a 1,4-bejzodiazepines